Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Karen Beltz
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
21
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A First-in-Human Phase 1/2 Dose-Escalation Study of Mak683 (Eed Inhibitor) in Patients with Advanced Malignancies
Number of pages: 21
Posted: 09 Oct 2024
Vincent Ribrag
,
Lara Iglesias
,
Filippo De Braudc
,
Brigette Ma
,
Tomoya Yokota
,
Thomas Zander
,
Anna Spreafico
,
Vivek Subbiah
,
Anna Lena Illerti
,
Daniel S. W. Tan
,
Armando Santoro
,
Pamela N. Munster
,
Youko Suehiro
,
Yongsheng Wang
,
Dong-Mei Ji
,
Shuqi Chen
, Karen Beltz,
Naoko Suenagau
,
Ramkumar Thiruvamoor
,
Fangjun Luo
,
Clinton Lai
and
Zev A. Wainberg
Gustave Roussy - Drug Development Department (DITEP), Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre,
affiliation not provided to SSRN
, The Chinese University of Hong Kong (CUHK), Shizuoka Cancer Center, University of Cologne, University of Toronto - Princess Margaret Cancer Centre, Sarah Cannon Research Institute,
affiliation not provided to SSRN
, National Cancer Centre Singapore - Division of Medical Oncology, Humanitas University - Department of Biomedical Sciences,
affiliation not provided to SSRN
, National Hospital Organization Kyushu Cancer Center - Department of Hematology and Cell Therapy,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
and
affiliation not provided to SSRN
Downloads
21
(1,448,301)
View PDF
Download
Abstract:
MAK683, EED, PRC2, DLBCL, ES, dose-escalation
Feedback